Review
doi: 10.1210/jcem.85.7.6702.
Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases
Affiliations
- PMID: 10902778
- DOI: 10.1210/jcem.85.7.6702
Item in Clipboard
Review
Clinical review 114: hot topic. The role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases
J Clin Endocrinol Metab.
2000 Jul.
No abstract available
Similar articles
-
[Osteoprotegerin ligand and osteoprotegerin: new concepts of the pathogenesis and therapy of metabolic bone diseases].Dtsch Med Wochenschr. 2001 Feb 9;126(6):145-50. doi: 10.1055/s-2001-11050. Dtsch Med Wochenschr. 2001. PMID: 11233883 Review. German. No abstract available.
-
[Osteoclastogenesis inhibitory factor (OCIF)/OPG (a novel therapeutic candidate for the treatment of metabolic bone diseases)].Nihon Rinsho. 2002 Mar;60 Suppl 3:679-87. Nihon Rinsho. 2002. PMID: 11979969 Review. Japanese. No abstract available.
-
Transcription Factor Decoy (TFD) as a novel approach for the control of osteoclastic resorption.Prog Orthod. 2005;6(2):238-47. Prog Orthod. 2005. PMID: 16276433 Review. English, Italian. No abstract available.
-
The osteoprotegerin/osteoprotegerin ligand family: role in inflammation and bone loss.J Rheumatol. 2004 May;31(5):844-6. J Rheumatol. 2004. PMID: 15124240 Review. No abstract available.
-
Glucocorticoid regulation of osteoclast differentiation and expression of receptor activator of nuclear factor-kappaB (NF-kappaB) ligand, osteoprotegerin, and receptor activator of NF-kappaB in mouse calvarial bones.Endocrinology. 2006 Jul;147(7):3613-22. doi: 10.1210/en.2005-0717. Epub 2006 Apr 13. Endocrinology. 2006. PMID: 16614077
Cited by
-
Autocrine motility factor and its receptor expression in musculoskeletal tumors.J Bone Oncol. 2020 Sep 14;24:100318. doi: 10.1016/j.jbo.2020.100318. eCollection 2020 Oct. J Bone Oncol. 2020. PMID: 33101887 Free PMC article. Review.
-
Update on the pathogenesis and genetics of Paget's disease of bone.Front Cell Dev Biol. 2022 Aug 12;10:932065. doi: 10.3389/fcell.2022.932065. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 36035996 Free PMC article. Review.
-
Vascular calcification in diabetic foot and its association with calcium homeostasis.Indian J Endocrinol Metab. 2012 Dec;16(Suppl 2):S450-2. doi: 10.4103/2230-8210.104128. Indian J Endocrinol Metab. 2012. PMID: 23565463 Free PMC article.
-
Anti-Osteoporosis Effect of Perilla frutescens Leaf Hexane Fraction through Regulating Osteoclast and Osteoblast Differentiation.Molecules. 2022 Jan 26;27(3):824. doi: 10.3390/molecules27030824. Molecules. 2022. PMID: 35164085 Free PMC article.
-
Bone mineral density, osteoporosis, and osteoporotic fractures: a genome-wide association study.Lancet. 2008 May 3;371(9623):1505-12. doi: 10.1016/S0140-6736(08)60599-1. Lancet. 2008. PMID: 18455228 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
